NCT00561756View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Lymphoma
Interventions
BIOLOGICAL

plasmid DNA vaccine therapy

OTHER

flow cytometry

OTHER

immunoenzyme technique

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00561756 - Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma | Biotech Hunter | Biotech Hunter